Search company, investor...

Founded Year

2018

Stage

Acquired | Acquired

Total Raised

$8.25M

About Emphysys

Emphysys is an interdisciplinary research and development firm located just outside of Boston in Woburn, Massachusetts.

Headquarters Location

2 Gill Street

Woburn, Massachusetts, 01801,

United States

339-227-6475

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Latest Emphysys News

June 2019 - MCRC Announces a New Investment in Emphysys, Inc. - Mass Capital

Dec 1, 2020

June 2019 – MCRC Announces a New Investment in Emphysys, Inc. MCRC is pleased to announce participation in a preferred equity investment led by Valero Capital to purchase a minority ownership stake in Emphysys, Inc. Founded in 2009 and based in Woburn, MA, Emphysys is a technology and product development firm with specialties in medical devices, semiconductor equipment, and industrial equipment. The Company partners with customers varying from start-ups to multi-billion-dollar corporations, leveraging their engineering expertise, to help provide design services for next generation products. For more information, please visit www.emphysys.com ABOUT MCRC Established in 1977, Massachusetts Capital Resource Company is a private limited partnership owned and funded by Massachusetts-based life insurance companies. MCRC provides junior capital to Massachusetts businesses, filling the gap between senior debt and equity. MCRC’s investments finance growth strategies, acquisitions, management buyouts and recapitalizations in a wide range of industries including manufacturing, distribution, consumer products, business services and technology. For more information, please visit our web site or call us at 617-536-3900. 617-536-3900 By admin |2019-12-05T16:02:50+00:00June 1st, 2019| Newsletters |Comments Off on June 2019 – MCRC Announces a New Investment in Emphysys, Inc. Share This Story, Choose Your Platform!

Emphysys Frequently Asked Questions (FAQ)

  • When was Emphysys founded?

    Emphysys was founded in 2018.

  • Where is Emphysys's headquarters?

    Emphysys's headquarters is located at 2 Gill Street, Woburn.

  • What is Emphysys's latest funding round?

    Emphysys's latest funding round is Acquired.

  • How much did Emphysys raise?

    Emphysys raised a total of $8.25M.

  • Who are the investors of Emphysys?

    Investors of Emphysys include Paramit, Massachusetts Capital Resource Company and Valero Capital Partners.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.